Stephen B. Soumerai is Professor of Population Medicine at Harvard Medical School and Harvard Pilgrim Health Care Institute, where he focuses on pharmaceutical outcomes, quality of health care studies and health policy. He also co-chaired the Statistics and Evaluative Sciences concentration within Harvard University’s health policy Ph.D. program for over 20 years, and continues as an active faculty member in the concentration. Dr. Soumerai has led or been a member of numerous NIH and international advisory and peer review committees for prioritizing and funding health policy research. He recently served as International Trustee for the Canadian Health Services Research Foundation. Dr. Soumerai is the recipient of numerous honors including numerous article of the year awards from national and international scientific societies, named lectureships, and the Everett Mendelsohn Excellence in Mentoring Award from the Harvard University Graduate School of Arts and Sciences.
Dr. Soumerai has published more than 250 original scientific articles in leading scientific journals, such as the New England Journal of Medicine and the Journal of the American Medical Association. He is well known nationally and internationally for his work on the impacts of health policies and methods to improve the quality of medical practice. His recent research has focused on cost-related underuse of medications; as well as the impacts of drug coverage and cost-containment policies on access to effective medications, quality and costs of care and clinical outcomes among vulnerable populations, and the unintended health outcomes of FDA warnings regarding use of antidepressants in children. He frequently advises Congress, state legislatures, and federal and international agencies on the design of drug cost containment, coverage and quality-of-care policies, and evidence-based health policy. His research has been used extensively to support expanded economic access to medications in Medicaid and Medicare.
Dr. Soumerai has published numerous op-eds in leading news outlets, including The Wall Street Journal, The Washington Post, Newsweek, The Huffington Post, The Boston Globe and the Health Affairs Blog on subjects including elimination of coverage gaps in the Medicare drug benefit, adverse consequences of rushed nationwide implementation of health IT, undertreatment of pain, required drug coverage in Massachusetts health reform plans, state censorship of health research, poor efficacy of pay-for-performance policies, and arbitrary economic penalties for hospital readmissions.
Dr. Soumerai's work focuses on demonstrating bias in research designs, improving the evidence basefor health policies, and "flip flopping" health research.